[go: up one dir, main page]

AR011780A1 - Estatina semi-sintetica y proceso para la produccion de estatinas semi- sinteticas a traves de intermediarios nuevos - Google Patents

Estatina semi-sintetica y proceso para la produccion de estatinas semi- sinteticas a traves de intermediarios nuevos

Info

Publication number
AR011780A1
AR011780A1 ARP980100381A ARP980100381A AR011780A1 AR 011780 A1 AR011780 A1 AR 011780A1 AR P980100381 A ARP980100381 A AR P980100381A AR P980100381 A ARP980100381 A AR P980100381A AR 011780 A1 AR011780 A1 AR 011780A1
Authority
AR
Argentina
Prior art keywords
semi
synthetic
statins
production
statin
Prior art date
Application number
ARP980100381A
Other languages
English (en)
Original Assignee
Plus Chemicals Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plus Chemicals Bv filed Critical Plus Chemicals Bv
Publication of AR011780A1 publication Critical patent/AR011780A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

Estatinas semisintéticas tales como smbastina, en muchos casos son preferibles a las erstatinas que se producen naturalmente, tal como lovastaína,en sus usos como agentes hipercolesterilemicos. Estas semi sintéticas estatinas contienen un grupo metil extra posicionado en la cadena lateral de 8-acilo.Muchas rutas para la introduccion de este grupo metil extra son conocidas en el arte. Un proceso para la produccion de semi sintéticas estatinas comprendenuevos intermediarios semi-sintéticos. Otro objeto de la invencion e s un proceso para obtener dichos intermediarios.
ARP980100381A 1997-01-28 1998-01-28 Estatina semi-sintetica y proceso para la produccion de estatinas semi- sinteticas a traves de intermediarios nuevos AR011780A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97200223 1997-01-28
EP97306809 1997-09-03

Publications (1)

Publication Number Publication Date
AR011780A1 true AR011780A1 (es) 2000-09-13

Family

ID=26146080

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980100381A AR011780A1 (es) 1997-01-28 1998-01-28 Estatina semi-sintetica y proceso para la produccion de estatinas semi- sinteticas a traves de intermediarios nuevos

Country Status (16)

Country Link
US (1) US6294680B1 (es)
EP (2) EP0971913B1 (es)
JP (1) JP2001508782A (es)
KR (1) KR100538674B1 (es)
AR (1) AR011780A1 (es)
AT (2) ATE237605T1 (es)
AU (1) AU747219C (es)
CA (1) CA2278603A1 (es)
DE (2) DE69813538T2 (es)
DK (1) DK0971913T3 (es)
ES (2) ES2197465T3 (es)
IL (1) IL131044A (es)
NO (1) NO318146B1 (es)
NZ (1) NZ336993A (es)
PT (1) PT971913E (es)
WO (1) WO1998032751A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0940395A1 (en) * 1998-03-05 1999-09-08 Synthon B.V. Process for producing simvastatin and/or its derivatives
NO991045L (no) 1998-03-05 1999-09-06 Synthon Bv FremgangsmÕte ved fremstilling av simvastatin og/eller dets derivater
CA2320163C (en) * 1998-12-10 2008-09-23 Kaneka Corporation Process for producing simvastatin
CO5140104A1 (es) 1999-02-16 2002-03-22 Novartis Ag Derivados de mevinolina y preparacion farmaceuticas que los contienen
KR20010009846A (ko) * 1999-07-14 2001-02-05 구광시 심바스타틴 제조에 유용한 중간체 및 그의 제조방법
WO2001034590A1 (en) * 1999-11-11 2001-05-17 Biocon India Limited Process for manufacturing simvastatin and the novel intermediates
US6573385B1 (en) 1999-11-11 2003-06-03 Biocon India Limited Process for manufacturing simvastatin and novel intermediates thereof
JP2004505045A (ja) * 2000-07-27 2004-02-19 プラス　ケミカルズ　ベスローテン　フェンノートシャップ 高純度シンバスタチン組成物
NL1017548C2 (nl) 2001-03-09 2002-09-10 Synthon Bv Een lactonisatie proces.
KR20040026705A (ko) 2001-08-16 2004-03-31 테바 파마슈티컬 인더스트리즈 리미티드 스타틴의 칼슘 염 형태의 제조 방법
US6472542B1 (en) 2001-11-29 2002-10-29 Fermic S.A. De C.V. Method for alkylating the alpha carbon of the 2-methylbutyrate secondary chain of lovastatin
KR100423892B1 (ko) * 2001-12-03 2004-03-22 씨제이 주식회사 스타틴의 제조에 있어서 새로운 락톤화 방법
SI21187A (sl) 2002-03-26 2003-10-31 Krka, Tovarna Zdravil D.D., Novo Mesto Postopek za pripravo 4-oksitetrahidropiran-2-onov
US6603022B1 (en) 2002-05-10 2003-08-05 Biocon India Limited Process for manufacturing Simvastatin and novel intermediates thereof
CA2515179A1 (en) 2003-02-11 2004-08-26 Ferenc Korodi Process for preparing simvastatin having controlled ranges of simvastatin dimer content
CN101415833B (zh) * 2003-10-21 2012-07-04 维莱尼姆公司 制备新伐他汀及中间体的方法
JP4621451B2 (ja) 2004-08-11 2011-01-26 富士フイルム株式会社 液浸露光用保護膜形成組成物及びそれを用いたパターン形成方法
WO2007030302A2 (en) * 2005-09-01 2007-03-15 Prescient Medical, Inc. Drugs coated on a device to treat vulnerable plaque
WO2007125547A2 (en) 2006-05-03 2007-11-08 Manne Satyanarayana Reddy Novel process for statins and its pharmaceutically acceptable salts thereof
US8404841B2 (en) 2006-10-09 2013-03-26 Msn Laboratories Limited Process for the preparation of statins and their pharmaceutically acceptable salts thereof
EP2387561A4 (en) 2009-01-19 2012-07-25 Msn Lab Ltd IMPROVED PROCESS FOR THE PREPARATION OF HIGH-PURITY (3R, 5S) -7-β-CYCLOPROPYL-4- (4-FLUOROPHENYL) QUINOLIN-3-YL-3,5-DIHYDROXY-6 (E) -HEPTENOIC ACID, INCLUDING ITS PHARMACEUTICALLY ACCEPTABLE SALTS
US8470805B2 (en) * 2009-04-30 2013-06-25 Kaohsiung Medical University Processes for preparing piperazinium salts of KMUP and use thereof
EP2526099B1 (en) 2010-01-18 2016-03-30 MSN Laboratories Limited Improved process for the preparation of amide intermediates and their use thereof
HU229260B1 (en) * 2010-11-29 2013-10-28 Egis Gyogyszergyar Nyrt Process for preparation of rosuvastatin salts
CN110563680A (zh) * 2019-09-10 2019-12-13 山东罗欣药业集团恒欣药业有限公司 一种治疗高脂血症药物的制备方法
CN110483459A (zh) * 2019-09-10 2019-11-22 山东罗欣药业集团恒欣药业有限公司 一种辛伐他汀的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820850A (en) * 1987-07-10 1989-04-11 Merck & Co., Inc. Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
EP0415488B1 (en) * 1989-08-31 1994-04-20 Merck & Co. Inc. 7-Substituted HMG-COA reductase inhibitors
US5393893A (en) * 1993-11-08 1995-02-28 Apotex, Inc. Process for producing simvastatin and analogs thereof
EP0940395A1 (en) 1998-03-05 1999-09-08 Synthon B.V. Process for producing simvastatin and/or its derivatives

Also Published As

Publication number Publication date
NO993644L (no) 1999-09-28
US6294680B1 (en) 2001-09-25
DE69834279T2 (de) 2007-01-04
ATE323689T1 (de) 2006-05-15
AU6618398A (en) 1998-08-18
DE69813538D1 (de) 2003-05-22
AU747219C (en) 2003-11-20
ATE237605T1 (de) 2003-05-15
EP1340752A1 (en) 2003-09-03
ES2197465T3 (es) 2004-01-01
ES2266671T3 (es) 2007-03-01
DE69813538T2 (de) 2004-04-01
KR20000070501A (ko) 2000-11-25
DE69834279D1 (de) 2006-05-24
PT971913E (pt) 2003-08-29
AU747219B2 (en) 2002-05-09
NZ336993A (en) 2000-05-26
JP2001508782A (ja) 2001-07-03
NO318146B1 (no) 2005-02-07
KR100538674B1 (ko) 2005-12-26
EP1340752B1 (en) 2006-04-19
NO993644D0 (no) 1999-07-27
IL131044A (en) 2003-07-31
IL131044A0 (en) 2001-01-28
DK0971913T3 (da) 2003-08-04
CA2278603A1 (en) 1998-07-30
WO1998032751A1 (en) 1998-07-30
EP0971913A1 (en) 2000-01-19
EP0971913B1 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
AR011780A1 (es) Estatina semi-sintetica y proceso para la produccion de estatinas semi- sinteticas a traves de intermediarios nuevos
ES2183331T3 (es) Inhibidores de sulfamida-metaloproteasa.
CR6392A (es) Moduladores de ccr5
GT200200066A (es) Empleo de etoxilatos de alcoholes grasos como favorecedores de la penetracion
ES2190440T3 (es) Compuestos antitumorales, composiciones farmaceuticas, modos de preparacion y para el tratamiento.
AR008861A1 (es) COMPUESTOS DE LACTAMA E IMIDA HETEROCICLICOS DE ARALQUILO Y ARALQUILEDENO, COMPUESTOS INTERMEDIARIOS PARA SU SíNTESIS, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN.
ES2155069T3 (es) Inhibidores de proteasas retrovirales.
GT200300150A (es) Inhibidores de quinasas
ES2164842T3 (es) Procedimiento para la preparacion de composiciones de microcapsulas.
PA8462301A1 (es) Combinacion de un inhibidor de la aldosa reductasa y un inhibidor de la glucogeno fosforilasa
HN2000000051A (es) Derivados heterociclicos utiles como agentes anticancerosos
ES2098140T3 (es) Liosferas que contienen gonadotropina.
ES2116436T5 (es) Carbamatos y agentes fitosanitarios que contienen estos.
ES2045180T3 (es) Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas.
ES2136725T3 (es) Utilizacion de 2-amino-6-n-propil-amino-4,5,6,7-tetrahidrobenzotiazol (pramipexol) como medicamento con efecto antidepresivo.
MX9301129A (es) Nuevas ciclosporinas y composiciones farmaceuticas que las contienen.
ES2179208T3 (es) Derivados hidrofobos de taxano que favorecen la hidrolisis.
ES2099039B1 (es) Bioabsorbente para metales pesados preparado a partir de biomasa.
SE9901077D0 (sv) Novel use
ES2105217T3 (es) Preparacion de intermedios en la sintesis de antibioticos de quinolina.
BR9606981A (pt) Processo para preparação de intermediários inibidores de protease retroviral
MX9704490A (es) Tratamiento terapeutico combinado de las patologias hiperproliferativas.
UY26666A1 (es) Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
ES2066927T3 (es) Procedimiento para la purificacion de polialquileneterglicoles, que contienen heteropoliacidos.
PE20050120A1 (es) Camptotecinas con un anillo de lactona modificada

Legal Events

Date Code Title Description
FB Suspension of granting procedure